Bezabih T, Agidew S, Kebede S, Belay M, Siyoum E, Ashenafi E
Contracept Reprod Med. 2024; 9(1):22.
PMID: 38741215
PMC: 11089669.
DOI: 10.1186/s40834-024-00263-1.
Figa Z, Chekole T, Tarekegn D, Mahamed A, Bekele E
Heliyon. 2023; 9(6):e15972.
PMID: 37251447
PMC: 10220320.
DOI: 10.1016/j.heliyon.2023.e15972.
Gashaye K, Gebresilassie K, Kassie B, Zenebe C, Mengistu Z, Ferede S
BMC Womens Health. 2023; 23(1):273.
PMID: 37208658
PMC: 10199468.
DOI: 10.1186/s12905-023-02375-3.
Maceira D, Oizerovich S, Perrotta G, Ponce de Leon R, Karolinski A, Suarez N
Sex Reprod Health Matters. 2023; 31(1):2189507.
PMID: 37042700
PMC: 10101666.
DOI: 10.1080/26410397.2023.2189507.
Lombardi Fah V, Catarino R, Castillo S, Badda M, Gezer-Dickschat S, Thieringer F
BMC Res Notes. 2023; 16(1):35.
PMID: 36915205
PMC: 10010063.
DOI: 10.1186/s13104-023-06304-3.
An Interpretative Study of LARCs Discontinuation in Ethiopia: The Experiences of Women Accessing Contraceptives in Selected Public Health Facilities.
Mihretie G, Abebe S, Abera M, Assefa D
Open Access J Contracept. 2023; 14:41-51.
PMID: 36824684
PMC: 9942686.
DOI: 10.2147/OAJC.S394590.
Discontinuation of long acting reversible contraceptive use and its determinants among women in Ethiopia: Systematic review and meta-analysis.
Gebeyehu N, Tegegne K, Biset G, Sewuyew D, Alemu B, Yitayew A
Front Public Health. 2022; 10:979231.
PMID: 36561863
PMC: 9763286.
DOI: 10.3389/fpubh.2022.979231.
Reasons given by women for discontinuing the use of progestogen implants at Koster Hospital, North West province.
Olaifa B, Okonta H, Mpinda J, Govender I
S Afr Fam Pract (2004). 2022; 64(1):e1-e7.
PMID: 36331205
PMC: 9724037.
DOI: 10.4102/safp.v64i1.5471.
Early Implanon discontinuation and associated factors among Implanon women users visiting public health facilities, in Kembata zone of Southern Ethiopia: An institution based cross-sectional study.
Beyene G, Assefa N, Mokonnon T, Ejigu H, Yadeta T
Front Glob Womens Health. 2022; 3:909411.
PMID: 36051576
PMC: 9426357.
DOI: 10.3389/fgwh.2022.909411.
The prevalence of Implanon discontinuation and associated factors among Ethiopian women: A systematic review and meta-analysis.
Habte A, Tamene A, Woldeyohannes D, Bogale B, Ermias D, Endale F
Womens Health (Lond). 2022; 18:17455057221109222.
PMID: 35762596
PMC: 9244932.
DOI: 10.1177/17455057221109222.
Determinants of early discontinuation of etonogestrel sub-dermal implant among reproductive-age women in Legambo district, Northeast Ethiopia: An unmatched case-control study.
Yimer Y, Cherie N, Damtie Y
SAGE Open Med. 2022; 10:20503121221088102.
PMID: 35371479
PMC: 8969501.
DOI: 10.1177/20503121221088102.
Incidence and predictors of first-year unplanned discontinuation of Implanon at Ayder comprehensive specialized hospital, northern Ethiopia: A retrospective follow-up study.
Abraha H, Gezae K, Kahsay A, Tequare M
PLoS One. 2022; 17(1):e0259234.
PMID: 35081115
PMC: 8791466.
DOI: 10.1371/journal.pone.0259234.
Introducing Long-Acting Contraceptive Removal Indicators in a Pilot Study in Mozambique: Dynamics of Discontinuation and Implications for Quality of Care.
Jacinto A, Ronda A, Lee C, Fikree F, Ramirez-Ferrero E
Glob Health Sci Pract. 2022; 10(1).
PMID: 35040804
PMC: 8885348.
DOI: 10.9745/GHSP-D-21-00252.
Menstrual Pattern and Characteristics of One-Rod and Two-Rod Levonorgestrel Implant Users.
Gunardi E, Susilo S
Obstet Gynecol Int. 2021; 2021:2904542.
PMID: 33777145
PMC: 7972863.
DOI: 10.1155/2021/2904542.
A systematic review on clinical effectiveness, side-effect profile and meta-analysis on continuation rate of etonogestrel contraceptive implant.
Moray K, Chaurasia H, Sachin O, Joshi B
Reprod Health. 2021; 18(1):4.
PMID: 33407632
PMC: 7788930.
DOI: 10.1186/s12978-020-01054-y.
Discontinuation of implants use and associated factors among women attending health facility clinics in Hawassa City, Southern Ethiopia, 2019; cross sectional study.
Amare Abebe B, Reda Terefe M
Contracept Reprod Med. 2020; 5:29.
PMID: 33110625
PMC: 7583256.
DOI: 10.1186/s40834-020-00128-3.
Prevalence and factors associated with early discontinuation rate of Implanon utilization among women who ever used Implanon in Kucha District Gamo Gofa Zone, Southern Ethiopia.
Mamecha Mesha , Alemayehu A, Daka D
BMC Womens Health. 2020; 20(1):239.
PMID: 33097056
PMC: 7583223.
DOI: 10.1186/s12905-020-01096-1.
Discontinuation of Reversible Long-Acting Contraceptive and Associated Factors among Female Users in Health Facilities of Hawassa City, Southern Ethiopia: Cross-Sectional Study.
Amare Abebe B, Assefa N, Mengistie B
Open Access J Contracept. 2020; 11:113-123.
PMID: 32943951
PMC: 7480761.
DOI: 10.2147/OAJC.S259978.
Incidence and determinants of Implanon discontinuation: Findings from a prospective cohort study in three health zones in Kinshasa, DRC.
Akilimali P, J H, P A, K P K, J B
PLoS One. 2020; 15(5):e0232582.
PMID: 32392216
PMC: 7213683.
DOI: 10.1371/journal.pone.0232582.
Discontinuation rate of Implanon and its associated factors among women who ever used Implanon in Dale District, Southern Ethiopia.
Nageso A, Gebretsadik A
BMC Womens Health. 2018; 18(1):189.
PMID: 30453931
PMC: 6245529.
DOI: 10.1186/s12905-018-0678-x.